Results 231 to 240 of about 129,551 (302)

Generative AI, ESG Sensemaking, and Environmental Performance: an OIPT Perspective

Business Strategy and the Environment, EarlyView.
ABSTRACT Despite growing enthusiasm for generative artificial intelligence (GenAI) in sustainability management, it remains unclear how such technologies translate vast ESG information into meaningful environmental outcomes. This study addresses this gap by investigating how ESG sensemaking capability mediates the relationship between GenAI integration
Surajit Bag, Gautam Srivastava, Susmi Routray, Andrea Chiarini   +3 more
wiley   +1 more source

Annual Reports to the ESA Council ESA 110th Annual Meeting July, 2025

The Bulletin of the Ecological Society of America, EarlyView.
wiley   +1 more source

Navigating the ESG Paradox: Strategic Pathways Between Innovation and Washing Under Stakeholder Scrutiny

Business Strategy and the Environment, EarlyView.
ABSTRACT As firms increasingly incorporate environmental, social, and governance (ESG) concerns into their strategic agendas, stakeholder legitimacy—an audience‐conferred judgment of organizational appropriateness—has become pivotal. We theorize legitimacy as expanding a hybrid response portfolio in which firms may pursue substantive change (business ...
Min‐Jae Lee, Anna Pak, Donghwi (Josh) Seo, Taewoo Roh   +3 more
wiley   +1 more source

The Essential Role of Medical Monitors in Clinical Trials. [PDF]

Cureus
Klein GL, Barabash E, Morgan RE, Brown G, Tulchinskiy M, Byrth F, Jones Amaowei E, Vukojevic P, Vaezzadeh S, Dawson KL, Cohn G, Haworth S, Blackwood-Chirchir A, Wolff J, Overton A.   +14 more
europepmc   +1 more source

A Business Framework for Product Take‐Back—A Structured Multiple‐Case Analysis

Business Strategy and the Environment, EarlyView.
ABSTRACT The potential of take‐back systems remains largely unrealized as initiatives have proven difficult to implement in practice. The question is why we do not see more take‐back systems given the substantial environmental benefits. We try to understand the challenges and stumbling blocks in setting up take‐back from a business perspective.
Rasmus Jørgensen, Torben Pedersen
wiley   +1 more source

Including patient and public contributors on clinical trial Independent Data Monitoring Committees (IDMCs). [PDF]

Trials
Allaway E, Soulsby I, Keyworth N, Stanton L, Saunders G, Caddy J, Boxall C, Griffiths G.   +7 more
europepmc   +1 more source

Scottish Burgh Record Scholarship c. 1830-1880 [PDF]

, 2009
Marsden, Richard
core  

iForal: Automated Handwritten Text Transcription for Historical Medieval Manuscripts. [PDF]

J Imaging
Matos A, Almeida P, Correia PL, Pacheco O.   +3 more
europepmc   +1 more source

Ethical preparedness of data monitoring committees (DMCs) to oversee international clinical trials: a qualitative descriptive study. [PDF]

BMJ Glob Health
Hinga A, Ibrahim A, Vintimilla D, Jones M, Eckstein L, Rid A, Shah SK, Kamuya D.   +7 more
europepmc   +1 more source

Drones in Health Care-A Flying Potential. [PDF]

Indian J Community Med
Agarwalla R, Sarma P, Puranik A, Bhattacharyya H.   +3 more
europepmc   +1 more source